NICOLE CAMPBELL: Open Payments
NPI 1801317896 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,848 in 78 payments from 16 companies in 2025. Trend: 2023 $1,192 · 2024 $1,012 · 2025 $1,848
Food & beverage: $1,848
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $317 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $247 |
| ABBVIE INC. | 14 | $229 |
| Gilead Sciences, Inc. | 7 | $175 |
| Phathom Pharmaceuticals, Inc. | 6 | $144 |
| Madrigal Pharmaceuticals | 4 | $133 |
| Ardelyx, Inc. | 4 | $104 |
| Intercept Pharmaceuticals, Inc. | 3 | $85 |
| QOL Medical, LLC | 2 | $85 |
| Janssen Biotech, Inc. | 3 | $84 |
Products named: XIFAXAN, ENTYVIO, VOQUEZNA, REZDIFFRA, IBSRELA, OCALIVA, Sucraid, TREMFYA.
Industry payments across RI — which companies pay providers there.
